Analyst Viewpoint
Excessive smoking and alcohol consumption and surge in demand for endoscopic hemostasis are fostering the gastrointestinal bleeding treatment market size.
Gastrointestinal bleeding requires early diagnosis and appropriate treatments to ensure patient well-being. Increase in adoption of minimally invasive surgeries is augmenting market expansion.
Technological advancements in medical devices are generating lucrative gastrointestinal bleeding treatment market opportunities for the organizations in this business.
Moreover, companies in global market are investing in new product launches and research and development activities to enhance their product portfolio and provide accurate and effective treatments to the patients.
Gastrointestinal bleeding or gastrointestinal hemorrhage is bleeding that occurs within the gastrointestinal tract, which includes the organs involved in digestion from the mouth to the anus. Gastrointestinal (GI) bleeding can occur in various parts of the digestive system, including stomach, small intestine, esophagus, large intestine, and rectum.
Upper gastrointestinal bleeding and lower gastrointestinal bleeding are two major types of GI bleeding. The treatment for gastrointestinal bleeding depends on the underlying cause and severity of bleeding.
Fluid replacement, blood transfusion, endoscopic therapy, embolization, and surgery are some of the common treatments for gastrointestinal bleeding. Endoscopic hemostatic devices and closure devices are used for these treatments.
It is essential for individuals experiencing gastrointestinal bleeding to seek immediate medical attention to receive appropriate diagnosis and treatment.
| Attribute | Detail |
|---|---|
| Drivers |
|
Changing lifestyles and diets among the populations are leading to various diseases including gastrointestinal bleeding. Smoking increases the risk of developing gastrointestinal conditions, such as gastritis, gastroesophageal reflux disease (GERD), and peptic ulcers.
These conditions can cause irritation, inflammation, and damage to the lining of digestive tract. Excessive alcohol consumption can irritate and inflame the lining of stomach and esophagus, causing gastritis and esophagitis. Thus, excessive smoking and drinking habits are augmenting gastrointestinal bleeding treatment market development.
According to the World Health Organization (WHO), tobacco abuse and addiction lead to more than one million fatalities in India, which is one-sixth of the world deaths due to tobacco usage and accounts for 9.5% of all deaths in India.
Moreover, tobacco-related deaths will rise to a million, accounting for 10% of global deaths by 2030. Hence, increase in use of tobacco is fueling the gastrointestinal bleeding treatment market statistics.
Healthcare professionals prefer minimally invasive surgeries for various diseases as it has faster recovery time, fewer incisions, and less blood loss. Endoscopic hemostasis involves using an endoscope, a flexible tube with a camera, and light at its tip to visualize and treat bleeding lesions or blood vessels within the gastrointestinal tract.
Endoscopy enables direct visualization of the bleeding site, allowing physicians to accurately locate and assess the source of bleeding. Thus, surge in demand for endoscopic hemostasis is fostering the gastrointestinal bleeding treatment market value.
Technological advancements in surgical procedures allow surgeons to provide precise and effective treatments according to patient conditions and disease severity. Healthcare professionals use advanced equipment to ensure accuracy and efficiency. Thus, increase in investments in cutting-edge surgical devices is fueling the market progress.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
As per the latest gastrointestinal bleeding treatment market analysis, North America dominated the global market in 2022. Increase in hospitalization rates and well-established healthcare infrastructure is likely to propel the market share during the forecast period.
Moreover, increase in consumption of alcohol among teenagers and young adults is driving the market progress.
According to the 2022 National Survey on Drug Use and Health (NSDUH), 221.3 million people ages 12 and older (78.5% in this age group) reported that they drank alcohol at some point in their lifetime, which registered approximately 5.7 million youth ages 12 to 17 (22.3% in this age group) consumed alcoholic drinks.
As per the recent gastrointestinal bleeding treatment market trends, technological advancements in surgical procedures and developments in medical devices offer lucrative opportunities for companies in the industry.
Leading players in the market focus on future analysis of gastrointestinal bleeding treatment to provide appropriate solutions for the patients. Moreover, they are investing in research and development to introduce new medical devices and enhance their product portfolio.
Some of the players in the industry are Boston Scientific Corporation, Olympus Corporation, CONMED Corporation, Cook Group, Ovesco Endoscopy AG, Erbe Elektromedizin GmbH, STERIS, and US Medical Innovations.
These companies have been profiled in the gastrointestinal bleeding treatment market report based on various parameters including company overview, business segments, product portfolio, recent developments, business strategies, and financial overview.
| Attribute | Detail |
|---|---|
| Market Size in 2022 | US$ 518.3 Mn |
| Market Forecast (Value) in 2031 | US$ 824.9 Mn |
| Growth Rate (CAGR) | 5.4% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Tons | US$ Mn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
It was valued at US$ 518.3 Mn in 2022
It is projected to register a CAGR of 5.4% from 2023 to 2031
Excessive smoking and alcohol consumption and surge in demand for endoscopic hemostasis
North America was the most lucrative region in 2022
Boston Scientific Corporation, Olympus Corporation, CONMED Corporation, Cook Group, Ovesco Endoscopy AG, Erbe Elektromedizin GmbH, STERIS, and US Medical Innovations.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Gastrointestinal Bleeding Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Gastrointestinal Bleeding Treatment Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Gastrointestinal Bleeding Treatment Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Endoscopic Hemostatic Devices
6.3.1.1. Thermal Devices
6.3.1.2. Mechanical Devices
6.3.2. Closure Devices
6.3.3. Others
6.4. Market Attractiveness Analysis, by Product
7. Global Gastrointestinal Bleeding Treatment Market Analysis and Forecast, by GI Tract Division
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by GI Tract Division, 2017–2031
7.3.1. Upper GI Tract
7.3.2. Lower GI Tract
7.4. Market Attractiveness Analysis, by GI Tract Division
8. Global Gastrointestinal Bleeding Treatment Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Clinics
8.3.3. Ambulatory Surgical Centers
8.3.4. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Gastrointestinal Bleeding Treatment Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017–2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Gastrointestinal Bleeding Treatment Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Product, 2017–2031
10.3.1. Endoscopic Hemostatic Devices
10.3.1.1. Thermal Devices
10.3.1.2. Mechanical Devices
10.3.2. Closure Devices
10.3.3. Others
10.4. Market Value Forecast, by GI Tract Division, 2017–2031
10.4.1. Upper GI Tract
10.4.2. Lower GI Tract
10.5. Market Value Forecast, by End-user, 2017–2031
10.5.1. Hospitals
10.5.2. Clinics
10.5.3. Ambulatory Surgical Centers
10.5.4. Others
10.6. Market Value Forecast, by Country, 2017–2031
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Product
10.7.2. By GI Tract Division
10.7.3. By End-user
10.7.4. By Country
11. Europe Gastrointestinal Bleeding Treatment Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Product, 2017–2031
11.3.1. Endoscopic Hemostatic Devices
11.3.1.1. Thermal Devices
11.3.1.2. Mechanical Devices
11.3.2. Closure Devices
11.3.3. Others
11.4. Market Value Forecast, by GI Tract Division, 2017–2031
11.4.1. Upper GI Tract
11.4.2. Lower GI Tract
11.5. Market Value Forecast, by End-user, 2017–2031
11.5.1. Hospitals
11.5.2. Clinics
11.5.3. Ambulatory Surgical Centers
11.5.4. Others
11.6. Market Value Forecast, by Country/Sub-region, 2017–2031
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Product
11.7.2. By GI Tract Division
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific Gastrointestinal Bleeding Treatment Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Product, 2017–2031
12.3.1. Endoscopic Hemostatic Devices
12.3.1.1. Thermal Devices
12.3.1.2. Mechanical Devices
12.3.2. Closure Devices
12.3.3. Others
12.4. Market Value Forecast, by GI Tract Division, 2017–2031
12.4.1. Upper GI Tract
12.4.2. Lower GI Tract
12.5. Market Value Forecast, by End-user, 2017–2031
12.5.1. Hospitals
12.5.2. Clinics
12.5.3. Ambulatory Surgical Centers
12.5.4. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Product
12.7.2. By GI Tract Division
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America Gastrointestinal Bleeding Treatment Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Product, 2017–2031
13.3.1. Endoscopic Hemostatic Devices
13.3.1.1. Thermal Devices
13.3.1.2. Mechanical Devices
13.3.2. Closure Devices
13.3.3. Others
13.4. Market Value Forecast, by GI Tract Division, 2017–2031
13.4.1. Upper GI Tract
13.4.2. Lower GI Tract
13.5. Market Value Forecast, by End-user, 2017–2031
13.5.1. Hospitals
13.5.2. Clinics
13.5.3. Ambulatory Surgical Centers
13.5.4. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Product
13.7.2. By GI Tract Division
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa Gastrointestinal Bleeding Treatment Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Product, 2017–2031
14.3.1. Endoscopic Hemostatic Devices
14.3.1.1. Thermal Devices
14.3.1.2. Mechanical Devices
14.3.2. Closure Devices
14.3.3. Others
14.4. Market Value Forecast, by GI Tract Division, 2017–2031
14.4.1. Upper GI Tract
14.4.2. Lower GI Tract
14.5. Market Value Forecast, by End-user, 2017–2031
14.5.1. Hospitals
14.5.2. Clinics
14.5.3. Ambulatory Surgical Centers
14.5.4. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Product
14.7.2. By GI Tract Division
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. Boston Scientific Corporation
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Olympus Corporation
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. CONMED Corporation
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Cook Group
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Ovesco Endoscopy AG
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Erbe Elektromedizin GmbH
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. STERIS
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. US Medical Innovations
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
List of Tables
Table 01: Global Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 02: Global Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by GI Tract Division, 2017–2031
Table 03: Global Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Global Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 07: North America Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by GI Tract Division, 2017–2031
Table 08: North America Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 09: Europe Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 11: Europe Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by GI Tract Division, 2017–2031
Table 12: Europe Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Asia Pacific Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 15: Asia Pacific Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by GI Tract Division, 2017–2031
Table 16: Asia Pacific Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 17: Latin America Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Latin America Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 19: Latin America Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by GI Tract Division, 2017–2031
Table 20: Latin America Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Middle East & Africa Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Middle East & Africa Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 23: Middle East & Africa Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by GI Tract Division, 2017–2031
Table 24: Middle East & Africa Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Gastrointestinal Bleeding Treatment Market Size (US$ Mn) and Distribution (%), by Region, 2022–2031
Figure 02: Global Gastrointestinal Bleeding Treatment Market Revenue (US$ Mn), by Product, 2022
Figure 03: Global Gastrointestinal Bleeding Treatment Market Value Share, by Product, 2022
Figure 04: Global Gastrointestinal Bleeding Treatment Market Revenue (US$ Mn), by GI Tract Division, 2022
Figure 05: Global Gastrointestinal Bleeding Treatment Market Value Share, by GI Tract Division, 2022
Figure 06: Global Gastrointestinal Bleeding Treatment Market Revenue (US$ Mn), by End-user, 2022
Figure 07: Global Gastrointestinal Bleeding Treatment Market Value Share, by End-user, 2022
Figure 08: Global Gastrointestinal Bleeding Treatment Market Value Share, by Region, 2022
Figure 09: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, 2017–2031
Figure 10: Global Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Product, 2022–2031
Figure 11: Global Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by Product, 2023-2031
Figure 12: Global Gastrointestinal Bleeding Treatment Market Value Share Analysis, by GI Tract Division, 2022–2031
Figure 13: Global Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by GI Tract Division, 2023-2031
Figure 14: Global Gastrointestinal Bleeding Treatment Market Value Share Analysis, by End-user, 2022–2031
Figure 15: Global Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by End-user, 2022-2031
Figure 16: Global Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Region, 2022–2031
Figure 17: Global Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by Region, 2022-2031
Figure 18: North America Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 19: North America Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by Country, 2023–2031
Figure 20: North America Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Country, 2022–2031
Figure 21: North America Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Product, 2022–2031
Figure 22: North America Gastrointestinal Bleeding Treatment Market Value Share Analysis, by GI Tract Division, 2022–2031
Figure 23: North America Gastrointestinal Bleeding Treatment Market Value Share Analysis, by End-user, 2022–2031
Figure 24: North America Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by Product, 2023–2031
Figure 25: North America Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by GI Tract Division, 2023–2031
Figure 26: North America Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by End-user, 2023–2031
Figure 27: Europe Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 28: Europe Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 29: Europe Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 30: Europe Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Product, 2022–2031
Figure 31: Europe Gastrointestinal Bleeding Treatment Market Value Share Analysis, by GI Tract Division, 2022–2031
Figure 32: Europe Gastrointestinal Bleeding Treatment Market Value Share Analysis, by End-user, 2022–2031
Figure 33: Europe Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by Product, 2023–2031
Figure 34: Europe Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by GI Tract Division, 2023–2031
Figure 35: Europe Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by End-user, 2023–2031
Figure 36: Asia Pacific Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 37: Asia Pacific Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 38: Asia Pacific Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 39: Asia Pacific Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Product, 2022–2031
Figure 40: Asia Pacific Gastrointestinal Bleeding Treatment Market Value Share Analysis, by GI Tract Division, 2022–2031
Figure 41: Asia Pacific Gastrointestinal Bleeding Treatment Market Value Share Analysis, by End-user, 2022–2031
Figure 42: Asia Pacific Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by Product, 2023–2031
Figure 43: Asia Pacific Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by GI Tract Division, 2023–2031
Figure 44: Asia Pacific Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by End-user, 2023–2031
Figure 45: Latin America Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 46: Latin America Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 47: Latin America Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 48: Latin America Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Product, 2022–2031
Figure 49: Latin America Gastrointestinal Bleeding Treatment Market Value Share Analysis, by GI Tract Division, 2022–2031
Figure 50: Latin America Gastrointestinal Bleeding Treatment Market Value Share Analysis, by End-user, 2022–2031
Figure 51: Latin America Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by Product, 2023–2031
Figure 52: Latin America Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by GI Tract Division, 2023–2031
Figure 53: Latin America Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by End-user, 2023–2031
Figure 54: Middle East & Africa Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 55: Middle East & Africa Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 56: Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 57: Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Product, 2022–2031
Figure 58: Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Share Analysis, by GI Tract Division, 2022–2031
Figure 59: Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Share Analysis, by End-user, 2022–2031
Figure 60: Middle East & Africa Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by Product, 2023–2031
Figure 61: Middle East & Africa Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by GI Tract Division, 2023–2031
Figure 62: Middle East & Africa Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by End-user, 2023–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Gastrointestinal Bleeding Treatment Market
